- Home
- KLRS vs RVSB Comparison
KLRS vs RVSB Comparison
Compare KLRS & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- RVSB
- Stock Information
- Founded
- KLRS 2019
- RVSB 1923
- Country
- KLRS United States
- RVSB United States
- Employees
- KLRS N/A
- RVSB N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- RVSB Savings Institutions
- Sector
- KLRS Health Care
- RVSB Finance
- Exchange
- KLRS Nasdaq
- RVSB Nasdaq
- Market Cap
- KLRS 129.0M
- RVSB 119.6M
- IPO Year
- KLRS N/A
- RVSB 1993
- Fundamental
- Price
- KLRS $2.50
- RVSB $5.69
- Analyst Decision
- KLRS Buy
- RVSB Buy
- Analyst Count
- KLRS 1
- RVSB 1
- Target Price
- KLRS N/A
- RVSB $7.00
- AVG Volume (30 Days)
- KLRS 38.9K
- RVSB 252.3K
- Earning Date
- KLRS 08-15-2025
- RVSB 07-24-2025
- Dividend Yield
- KLRS N/A
- RVSB 1.40%
- EPS Growth
- KLRS N/A
- RVSB 27.97
- EPS
- KLRS N/A
- RVSB 0.23
- Revenue
- KLRS N/A
- RVSB $50,239,000.00
- Revenue This Year
- KLRS N/A
- RVSB $12.68
- Revenue Next Year
- KLRS N/A
- RVSB $11.53
- P/E Ratio
- KLRS N/A
- RVSB $24.65
- Revenue Growth
- KLRS N/A
- RVSB 3.95
- 52 Week Low
- KLRS $2.28
- RVSB $3.85
- 52 Week High
- KLRS $24.15
- RVSB $6.59
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- RVSB 57.09
- Support Level
- KLRS N/A
- RVSB $5.65
- Resistance Level
- KLRS N/A
- RVSB $5.85
- Average True Range (ATR)
- KLRS 0.00
- RVSB 0.14
- MACD
- KLRS 0.00
- RVSB 0.04
- Stochastic Oscillator
- KLRS 0.00
- RVSB 71.15
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.